京信通信(02342.HK)關注仿冒流動應用程式 澄清未有線上招商活動
京信通信(02342.HK)公布,近日有不法分子冒用「Comba」品牌和集團附屬「京信中國」名義以「Comba京信5G」為名的仿冒應用程式進行融資認籌等詐騙非法行為,聲稱京信中國授權某三家北京公司為其在內地的平台流動資金管理公司,並發佈於今年11月20-21日在廣州富力麗思卡爾頓酒店召開京信5G招商會議的虛假公告。
針對上述不實媒體消息,公司鄭重聲明,該平台與集團不存在任何關係;至今,集團旗下任何一家公司沒有實施任何融資認籌專案或線上招商活動,所謂京信5G招商會議是一個虛假訊息,集團沒有舉辦該會議;及集團從未授權任何一家公司為集團在內地的平台流動資金管理公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.